ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Improving Outcomes for Ewing Sarcoma Patients"
Episode Synopsis
In Ewing Sarcoma patients, exosomes in the blood may be an early detector of relapse. Partnering with the University of Kansas, Glenson Samuel, MD created a chip that could detect and analyze these exosomes and their proteins with minimum blood. Now, he is using that knowledge to find, and reverse, chemo-therapy-related resistance in tumor cells, making patients more responsive to therapy.Join Glenson Samuel, MD as he discusses his studies and his work with the genome center.
More episodes of the podcast Transformational Pediatrics
Histiocytosis Overview and Research
29/08/2025
Optical Genome Mapping
18/10/2024
Provider Burnout and Prioritizing Wellbeing
25/06/2024
In God we trust